Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Sarcoma; Sarcoma, Ewing | Phase 1/Phase 2 | ClinicalTrials |
| Neoplasms; Sarcoma | Phase 1 | ClinicalTrials |
| Sarcoma, Ewing | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 3 | ClinicalTrials |
| Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS